STEVE RODNEY: Open Payments
NPI 1336687136 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $105 |
| Indivior Inc. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $45 |
| Alkermes, Inc. | 1 | $29 |
| ViiV Healthcare Company | 1 | $27 |
Products named: REZDIFFRA, SUBLOCADE, MAVYRET, VIVITROL, Descovy, APRETUDE.
Industry payments across CA — which companies pay providers there.
